Premium
Moleculin Biotech Inc (MBRX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Mod... Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.09 | -7.89473684211 | 1.14 | 1.185 | 0.9945 | 532805 | 1.08584055 | CS |
| 4 | -0.15 | -12.5 | 1.2 | 1.64 | 0.9412 | 3470483 | 1.24105869 | CS |
| 12 | -0.6 | -36.3636363636 | 1.65 | 3.6499 | 0.3975 | 6163403 | 1.64529709 | CS |
| 26 | -1.78 | -62.8975265018 | 2.83 | 3.6499 | 0.3975 | 2782444 | 1.65317916 | CS |
| 52 | -4.95 | -82.5 | 6 | 6.2348 | 0.3975 | 1399966 | 1.68515477 | CS |
| 156 | -24.15 | -95.8333333333 | 25.2 | 30.75 | 0.3975 | 555157 | 3.62924278 | CS |
| 260 | -7.35 | -87.5 | 8.4 | 131.7 | 0.3975 | 1121902 | 21.87469037 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
